Typing of Human Papilloma Virus (HPV) From Female Genital Warts

• Register: ClinicalTrials.gov
• Last refreshed on: 19 October 2017
• Main ID: NCT01192282
• Date of registration: 31/08/2010
• Prospective Registration: No
• Primary sponsor: University of Cape Town
• Public title: Typing of Human Papilloma Virus (HPV) From Female Genital Warts
• Scientific title: Clinico-Pathological HPV DNA Typing Study of Women With Genital Warts Presenting to Groote Schuur Hospital Over a One Year Period, Evaluated by HIV Status, Psychological Impact and Costs to the Health Care System
• Date of first enrolment: April 2010
• Target sample size: 156
• Recruitment status: Completed
• URL: https://clinicaltrials.gov/show/NCT01192282
• Study type: Observational
• Phase: N/A

Countries of recruitment

South Africa

Contacts

• Name: Shahila Tayib, MBChB
• Affiliation: University of Cape Town

• Name: Lynette Denny
• Affiliation: University of Cape Town

Key inclusion & exclusion criteria

Inclusion Criteria:

- All female patients with genital warts

Exclusion Criteria:

- Patients who are pregnant, too frail or ill for gynaeoclogical examination and refusal
to participate



Age minimum: N/A
Age maximum: N/A
Gender: Female

Health Condition(s) or Problem(s) studied

Human Papilloma Virus

Genital Warts

Intervention(s)

Procedure: Medical / Surgical Treatment

Primary Outcome(s)

HPV DNA and HIV Status [Time Frame: 18 Months]

Number of HPV Genotypes Isolated by HIV Status [Time Frame: Up to 18 months]

HPV DNA and Pap Smear Results [Time Frame: 18 Months]

Commonest HPV Genotypes Isolated by HIV Status [Time Frame: 18 months]

Secondary ID(s)

131/2010

Source(s) of Monetary Support

Please refer to primary and secondary sponsors

Secondary Sponsor(s)

Merck Sharp & Dohme Corp.

Results

• Results available: Yes
• Date Posted: 15/01/2013
• URL: https://clinicaltrials.gov/ct2/show/results/NCT01192282